This ATM signaling pathway has been shown to play a role in other liver disease expressing high levels of oxidative stress such as metabolic dysfunction‐associated steatotic liver disease, hepatitis, and cholangitis (Daugherity et al., 2012; Matsuda et al., 2014; Sasaki et al., 2008). Here, ATM is linked to cholangitis.